Safety and Efficacy of HO/03/03 10microg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal).

Trial Profile

Safety and Efficacy of HO/03/03 10microg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers (Truheal).

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs HO 0303 (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Acronyms Truheal
  • Most Recent Events

    • 03 Apr 2013 Planned end date changed from 1 Feb 2013 to 1 Aug 2013 as reported by ClinicalTrials.gov.
    • 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 11 Jul 2012 Planned End Date 1 Feb 2013 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top